Skip to main content
. 2016 Nov 8;9:6909–6914. doi: 10.2147/OTT.S117338

Figure 1.

Figure 1

Expression of miR-486-5p in prostate cancer cell lines and clinical samples.

Notes: (A) The relative expression of miR-486-5p in the metastatic PCa cell line C4-2 is much lower than that in the non-metastatic LNCaP cell line. (B) The expression of miR-486-5p in clinical metastatic PCa specimens is significantly decreased compared to that in primary PCa tissues (**P<0.01). Each symbol represents the relative expression of each localized (●) or metastatic prostate cancer sample (▲).

Abbreviation: PCa, prostate cancer.